Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide (NCT07220642)
Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity
🩺 Plain-English Summary (8th-Grade Level)
This study will look at how much cagrilintide helps people with overweight or obesity lower their body weight. Cagrilintide is a new investigational medicine. Doctors may not yet prescribe cagrilintide. Participants will either get cagrilintide or placebo. Which treatment participants get is decided by chance. Participants are two times more likely to get cagrilintide than placebo. Like all medicines, the study medicine may have side effects. Possible side effects will be followed carefully during the study. For each participant, the study will last for about 1 year and 6 months.
Who can join: Review the eligibility criteria below.
Location: Diablo Clinical Research, Inc. — Walnut Creek, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (40 Sites)
Showing the first 25 of 40 sites.
- Diablo Clinical Research, Inc. — Walnut Creek, California
- Univ of Colorado at Denver — Aurora, Colorado
- Florida Inst For Clin Res LLC — Orlando, Florida
- Oviedo Medical Research, LLC — Oviedo, Florida
- Walgreens - Store 11760 — Oak Park, Illinois
- Midwest Inst For Clin Res — Indianapolis, Indiana
- StudyMetrix Research LLC — City of Saint Peters, Missouri
- PharmQuest Life Sciences LLC — Greensboro, North Carolina
- Selma Medical Associates — Winchester, Virginia
- CIPREC Pueyrredon — Buenos Aires,
- CEDIC Centro de Investigación Clínica — CABA,
- Sydney Cardiometabolic Centre — Liverpool, New South Wales
- Hunter Diabetes Centre — Merewether, New South Wales
- G.A. Research Associates Ltd. — Moncton, New Brunswick
- Nova Scotia Hlth Halifax — Halifax, Nova Scotia
- Hamilton Medical Research Group — Hamilton, Ontario
- Wharton Medical Clinic Clinical Trials (Hamilton) — Hamilton, Ontario
- Milestone Research — London, Ontario
- Centricity Research Oshawa — Oshawa, Ontario
- Centricity Research Toronto — Toronto, Ontario
- Centricity Research Mirabel — Mirabel, Quebec
- Centre Hospitalier Universitaire de Nantes-Hopital Nord Laennec — Saint-Herblain,
- Centre de Recherche Clinique Portes Du Sud — Vénissieux,
- InnoDiab Forschung GmbH — Essen,
- Wendisch - Dahl Hamburg - DZHW — Hamburg,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity
- Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools — Tampa, Florida
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity — Tucson, Arizona
- Piloting a Patient Navigator Program for Weight Loss — Philadelphia, Pennsylvania
- Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) — Mesa, Arizona
- Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects — Orlando, Florida
- Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans — Pittsburgh, Pennsylvania
Explore by condition: All Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.